In 2024, the Europe biosimilar market was valued at USD 13,864 million and is expected to grow to USD 59,733.3 million by 2033, with a CAGR of 17.1% during 2025-2033. Key growth factors include favorable reimbursement frameworks, increased production capacity, and continuous innovation in biosimilar technologies. https://www.imarcgroup.com/europe-biosimilar-market